PECAM-1: old friend, new partners

Newman, 1992, Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution, J Cell Biol, 119, 239, 10.1083/jcb.119.1.239

Lu, 1996, Integrin engagement mediates tyrosine dephosphorylation on platelet–endothelial cell adhesion molecule 1, Proc Natl Acad Sci USA, 93, 11808, 10.1073/pnas.93.21.11808

Jackson, 1997, The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation, J Biol Chem, 272, 6986, 10.1074/jbc.272.11.6986

Jackson, 1997, Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule -1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2, J Biol Chem, 272, 24868, 10.1074/jbc.272.40.24868

Newman, 2001, Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2 and p56lck, Blood, 97, 2351, 10.1182/blood.V97.8.2351

Sagawa, 1997, The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1(CD31), J Biol Chem, 272, 31086, 10.1074/jbc.272.49.31086

Ji, 2002, PECAM-1 (CD31) regulates a hydrogen peroxide-activated nonselective cation channel in endothelial cells, J Cell Biol, 157, 173, 10.1083/jcb.200110056

Masuda, 1997, Platelet endothelial cell adhesion molecule 1 is a major SH-PTP2 binding protein in vascular endothelial cells, FEBS Lett, 408, 331, 10.1016/S0014-5793(97)00457-2

Osawa, 1997, Tyrosine phosphorylation of platelet endothelial cell adhesion molecule 1 (PECAM-1, CD31) in mechanostimulated vascular endothelial cells, Eur J Cell Biol, 72, 229

Osawa, 2002, Evidence for a role of platelet endothelial cell adhesion molecule 1 and phosphoinositide 3-kinase in human neutrophils, J Cell Biol, 158, 1, 10.1083/jcb.200205049

Pinter, 1997, Platelet–endothelial cell adhesion molecule 1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus, Am J Pathol, 150, 1523

Pinter, 1999, Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state, Am J Pathol, 154, 1367, 10.1016/S0002-9440(10)65391-6

Lu, 1997, Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src–Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation-motif-like properties, J Biol Chem, 272, 14442, 10.1074/jbc.272.22.14442

Cao, 1998, Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases, J Biol Chem, 273, 15765, 10.1074/jbc.273.25.15765

Ilan, 2000, PECAM-1 (CD31): A scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation, J Biol Chem, 275, 21435, 10.1074/jbc.M001857200

Pellegatta, 1998, Functional association of platelet endothelial cell adhesion molecule 1 and phosphoinositide 3-kinase in human neutrophils, J Biol Chem, 273, 27768, 10.1074/jbc.273.43.27768

Pumphrey, 1999, Differential association of cytoplasmic signaling molecules SHP-1, SHP-2, SHIP and phospholipase C-γ1 with PECAM-1/CD31, FEBS Lett, 450, 77, 10.1016/S0014-5793(99)00446-9

Lanier, 2001, On guard-activating NK cell receptors, Nat Immunol, 2, 23, 10.1038/83130

Newman, 1999, Switched at birth: a new family for PECAM-1, J Clin Invest, 103, 5, 10.1172/JCI5928

Tomasello, 2000, Signaling pathways engaged by NK cell receptors: double concerto for activating receptor, inhibitory receptors and NK cells, Semin Immunol, 12, 139, 10.1006/smim.2000.0216

Newton-Nash, 1999, A new role for platelet–endothelial cell adhesion molecule 1 (CD31): inhibition of TCR-mediated signal transduction, J Immunol, 163, 682, 10.4049/jimmunol.163.2.682

Henshall, 2001, Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling, J Immunol, 16, 3098, 10.4049/jimmunol.166.5.3098

Patil, 2001, Platelet endothelial adhesion molecule 1 serves as inhibitory receptor that modulates platelet responses to collagen, Blood, 97, 1727, 10.1182/blood.V97.6.1727

Cicmil, 2002, Platelet endothelial cell adhesion molecule 1 signaling inhibits the activation of human platelets, Blood, 99, 137, 10.1182/blood.V99.1.137

Elias, 1998, Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils, Eur J Immunol, 28, 1948, 10.1002/(SICI)1521-4141(199806)28:06<1948::AID-IMMU1948>3.0.CO;2-C

Gratzinger, 2003, Platelet–endothelial cell adhesion molecule 1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif, Biochem Biophys Res Commun, 301, 243, 10.1016/S0006-291X(02)02982-0

Freeman, 1992, Identification of a human src-homology-2-containing protein tyrosine phosphatase: a putative homologue of Drosophila corkscrew, Proc Natl Acad Sci USA, 89, 11239, 10.1073/pnas.89.23.11239

Perkins, 1992, Corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso, Cell, 70, 225, 10.1016/0092-8674(92)90098-W

Stein-Gerlach, 1998, SHP-2, SH2-containing protein tyrosine phosphatase 2, Int J Biochem Cell Biol, 30, 559, 10.1016/S1357-2725(98)00002-8

Ilan, 1999, PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin, J Cell Sci, 112, 3005, 10.1242/jcs.112.18.3005

Ilan, 2001, PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics, FASEB J, 15, 362, 10.1096/fj.00-0372com

Cochrane, 2000, Identification of natural ligand for SH2 domains from a phage display cDNA library, J Mol Biol, 297, 89, 10.1006/jmbi.2000.3561

Birchmeier, 1996, Epithelial–mesenchymal transition in cancer progression, Acta Anat, 156, 217, 10.1159/000147848

Daniel, 1997, Tyrosine phosphorylation and cadherin/catenin function, Biol Essays, 19, 883

Provost, 1999, Controversies at the cytoplasmic face of the cadherin-based adhesion complex, Curr Opin Cell Biol, 11, 567, 10.1016/S0955-0674(99)00015-0

Schroeder, 2002, ErbB–β-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTB)-wnt-1 and MMTY-c-Neu transgenic carcinomas, J Biol Chem, 277, 22692, 10.1074/jbc.M201975200

Roura, 1999, Regulation of E-cadherin/catenin association by tyrosine phosphorylation, J Biol Chem, 274, 36734, 10.1074/jbc.274.51.36734

Piedra, 2001, Regulation of β-catenin structure and activity phosphorylation, J Biol Chem, 276, 20436, 10.1074/jbc.M100194200

Bienz, 2000, Linking colorectal cancer to Wnt signaling, Cell, 103, 311, 10.1016/S0092-8674(00)00122-7

Matsumura, 1997, Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin, J Immunol, 158, 3408, 10.4049/jimmunol.158.7.3408

Abedi, 1997, Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells, J Biol Chem, 273, 15442, 10.1074/jbc.272.24.15442

Esser, 1998, Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells, J Cell Sci, 111, 1853, 10.1242/jcs.111.13.1853

Wang, 2003, Modulation of PECAM-1 expression and alternative splicing during differentiation and activation of hematopoietic cells, J Cell Biochem, 88, 1012, 10.1002/jcb.10451

Wang, 2003, Tissue-specific distributions of alternatively spliced human PECAM-1 isoforms, Am J Physiol Heart Circ Physiol, 284, H1008, 10.1152/ajpheart.00600.2002

Nawroth, 2002, VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts, EMBO J, 21, 4885, 10.1093/emboj/cdf497

Taddei, 2002, β-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell–cell adhesion increase, Cancer Res, 62, 6489

Graesser, 2002, Changes in vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1 (CD31) deficient mice, J Clin Invest, 109, 383, 10.1172/JCI0213595

Ayalon, 1994, Spatial and temporal relationship between cadherin and PECAM-1 in cell–cell junctions of human endothelial cells, J Cell Biol, 126, 247, 10.1083/jcb.126.1.247

Brown, 2002, Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment, Nature, 418, 200, 10.1038/nature00811

Ilan, 2001, PECAM-1 is a modulator of stat family member phosphorylation and localization: lessons from a transgenic mouse, Dev Biol, 232, 219, 10.1006/dbio.2001.0186

Groner, 2000, Linear and cooperative signaling: roles for Stat proteins in the regulation of cell survival and apoptosis in the mammary epithelium, Breast Can Res, 2, 149, 10.1186/bcr47

Bartoli, 2000, Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells, J Biol Chem, 275, 33189, 10.1074/jbc.C000318200

Alon, 1995, Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity, Nat Med, 1, 1024, 10.1038/nm1095-1024

Benjamin, 1999, Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal, J Clin Invest, 103, 159, 10.1172/JCI5028

Ilan, 1998, Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis, J Cell Sci, 111, 3621, 10.1242/jcs.111.24.3621

Scatena, 2002, The αvβ3 integrin, NF-κB osteoprotegerin, endothelial cell survival pathway. Potential role in angiogenesis, Trends Cardiovasc Med, 12, 83, 10.1016/S1050-1738(01)00151-7

Carmeliet, 1999, Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis, Cell, 98, 147, 10.1016/S0092-8674(00)81010-7

Bird, 1999, Hemophilic PECAM-1 (CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration, J Cell Sci, 112, 1989, 10.1242/jcs.112.12.1989

Evans, 2001, Signaling through CD31 protects endothelial cells from apoptosis, Transplantation, 71, 457, 10.1097/00007890-200102150-00020

Ferrero, 2003, Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation, Blood, 101, 186, 10.1182/blood-2002-03-0768

Nobel, 1999, Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis, J Immunol, 162, 1376, 10.4049/jimmunol.162.3.1376

Serebruany, 1999, Soluble PECAM-1, but not P-selectin nor osteonectin, identify acute myocardial infraction in patients with chest pain, Cardiology, 9, 50, 10.1159/000006876

Zaremba, 2002, sPECAM-1 in serum and CSF of acute ischemic stroke patients, Acta Neurol Scand, 106, 292, 10.1034/j.1600-0404.2002.01339.x

Losy, 1999, Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions, J Neuroimmunol, 99, 169, 10.1016/S0165-5728(99)00092-2

Liao, 1997, Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial cell migration invitro and in vivo, J Exp Med, 185, 1349, 10.1084/jem.185.7.1349

Liao, 2000, Transgenic mice expressing different levels of soluble platelet/endothelial-cell-adhesion-molecule–lgG display distinct inflammatory phenotypes, J Immunol, 163, 5640, 10.4049/jimmunol.163.10.5640

Hakak, 2000, SHP-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt, Oncogene, 19, 3164, 10.1038/sj.onc.1203655

Wu, 2001, The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol-3-kinase/Akt activation by growth factors, Oncogene, 20, 6018, 10.1038/sj.onc.1204699

Enciso, 2003, Elevated glucose inhibits VEGF-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2, J Cell Biol, 160, 605, 10.1083/jcb.200209014

Miquerol, 2000, Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression, Development, 127, 3941, 10.1242/dev.127.18.3941

Pinter, 2001, Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF expression and VEGF receptor activation, Am J Pathol, 158, 1199, 10.1016/S0002-9440(10)64069-2

Ara, 2000, Membrane type-1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade, Cancer Lett, 157, 115, 10.1016/S0304-3835(00)00494-8

Yokoyama, 2003, Increased invasion and matrix metalloproteinase-2 expression by snail-induced mesenchymal transition in squamous cell carcinomas, J Oncol, 22, 891

Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ: PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 2003, in press.

Mamdouh, 2003, Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis, Nature, 421, 748, 10.1038/nature01300

Gratzinger D, Canosa S, Engelhardt B, Madri JA: Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. FASEB J 2003, in press.